Cargando…
Inhibitory effects of curcumin and cyclocurcumin in 1-methyl-4-phenylpyridinium (MPP(+)) induced neurotoxicity in differentiated PC12 cells
Development and progression of neurodegenerative diseases like Parkinson’s disease (PD) involve multiple pathways. Thus, effective therapeutic treatments should intervene to address all these pathways simultaneously for greater success. Most of the current pharmacotherapeutic approaches just supplem...
Autores principales: | Chakraborty, Sandeep, Karmenyan, Artashes, Tsai, Jin-Wu, Chiou, Arthur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717177/ https://www.ncbi.nlm.nih.gov/pubmed/29209088 http://dx.doi.org/10.1038/s41598-017-17268-3 |
Ejemplares similares
-
Proteomic analysis of S-nitrosylation induced by 1-methyl-4-phenylpyridinium (MPP(+))
por: Komatsubara, Akira T, et al.
Publicado: (2012) -
Ramelteon ameliorated 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in neuronal cells in a mitochondrial-dependent pathway
por: Li, Chuo, et al.
Publicado: (2021) -
Paeonolum protects against MPP(+)-induced neurotoxicity in zebrafish and PC12 cells
por: Lu, Xi-Lin, et al.
Publicado: (2015) -
Quantification of the Metabolic State in Cell-Model of Parkinson’s Disease by Fluorescence Lifetime Imaging Microscopy
por: Chakraborty, Sandeep, et al.
Publicado: (2016) -
The Interaction Affinity between Vascular Cell Adhesion Molecule-1 (VCAM-1) and Very Late Antigen-4 (VLA-4) Analyzed by Quantitative FRET
por: Chakraborty, Sandeep, et al.
Publicado: (2015)